Iradimed Corporation (NASDAQ:IRMD) Shares Sold by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC cut its stake in Iradimed Corporation (NASDAQ:IRMD) by 9.1% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,063 shares of the medical equipment provider’s stock after selling 4,500 shares during the period. Los Angeles Capital Management LLC owned 0.36% of Iradimed worth $2,266,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of the stock. Principal Financial Group Inc. acquired a new stake in shares of Iradimed during the third quarter worth $246,000. Oak Ridge Investments LLC acquired a new position in shares of Iradimed in the third quarter valued at about $2,188,000. Semanteon Capital Management LP acquired a new stake in shares of Iradimed during the third quarter worth about $331,000. Albert D Mason Inc. purchased a new stake in Iradimed in the third quarter valued at approximately $737,000. Finally, Copeland Capital Management LLC increased its holdings in Iradimed by 0.3% in the 3rd quarter. Copeland Capital Management LLC now owns 422,425 shares of the medical equipment provider’s stock worth $21,244,000 after buying an additional 1,433 shares during the period. Hedge funds and other institutional investors own 92.34% of the company’s stock.

Iradimed Stock Down 2.6 %

Shares of IRMD stock opened at $55.45 on Thursday. The stock has a market cap of $702.72 million, a PE ratio of 37.98 and a beta of 0.79. Iradimed Corporation has a 52-week low of $40.05 and a 52-week high of $57.95. The business has a 50-day simple moving average of $50.30 and a 200-day simple moving average of $46.32.

Iradimed Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 25th. Shareholders of record on Friday, November 15th will be given a $0.15 dividend. The ex-dividend date is Friday, November 15th. This represents a $0.60 annualized dividend and a yield of 1.08%. Iradimed’s dividend payout ratio is presently 41.10%.

Wall Street Analysts Forecast Growth

Separately, Roth Mkm dropped their price objective on shares of Iradimed from $65.00 to $60.00 and set a “buy” rating on the stock in a report on Friday, August 2nd.

Iradimed Company Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.